114 related articles for article (PubMed ID: 34451875)
1. The Positive Correlations between the Expression of Histopathological Ubiquitin-Conjugating Enzyme 2O Staining and Prostate Cancer Advancement.
Kim JH; Yang HJ; Lee CH; Jeon YS; Park JJ; Lee KW; Kim JH; Park SY; Song SJ; Kim YH; Moon AR; Lee JH; Song YS
Pharmaceuticals (Basel); 2021 Aug; 14(8):. PubMed ID: 34451875
[TBL] [Abstract][Full Text] [Related]
2. The correlation between the expression of ubiquitin-conjugating enzyme 2C and prostate cancer prognosis.
Kim JH; Lee KW; Yang HJ; Park JJ; Lee CH; Jeon YS; Yun JH; Park S; Song SJ; Kim YH; Lee JH; Moon A; Song YS
J Cancer Res Clin Oncol; 2023 Aug; 149(9):6351-6360. PubMed ID: 36752909
[TBL] [Abstract][Full Text] [Related]
3. Ubiquitin-conjugating enzyme UBE2O regulates cellular clock function by promoting the degradation of the transcription factor BMAL1.
Chen S; Yang J; Zhang Y; Duan C; Liu Q; Huang Z; Xu Y; Zhou L; Xu G
J Biol Chem; 2018 Jul; 293(29):11296-11309. PubMed ID: 29871923
[TBL] [Abstract][Full Text] [Related]
4. A new duet in cancer biology: AMPK the typical and UBE2O the atypical.
Vila IK; Song SJ; Song MS
Mol Cell Oncol; 2017; 4(3):e1304846. PubMed ID: 28616582
[No Abstract] [Full Text] [Related]
5. UBE2O promotes the proliferation, EMT and stemness properties of breast cancer cells through the UBE2O/AMPKα2/mTORC1-MYC positive feedback loop.
Liu X; Ma F; Liu C; Zhu K; Li W; Xu Y; Li G; Niu Z; Liu J; Chen D; Li Z; Fu Y; Qian C
Cell Death Dis; 2020 Jan; 11(1):10. PubMed ID: 31907353
[TBL] [Abstract][Full Text] [Related]
6. The Correlations between the Intensity of Histopathological Ubiquitin-Specific Protease 11 Staining and Progression of Prostate Cancer.
Kim JH; Yang HJ; Lee KW; Park JJ; Lee CH; Jeon YS; Kim JH; Park S; Song SJ; Lee JH; Moon A; Kim YH; Song YS
Pharmaceuticals (Basel); 2023 Dec; 16(12):. PubMed ID: 38139829
[TBL] [Abstract][Full Text] [Related]
7. A UBE2O-AMPKα2 Axis that Promotes Tumor Initiation and Progression Offers Opportunities for Therapy.
Vila IK; Yao Y; Kim G; Xia W; Kim H; Kim SJ; Park MK; Hwang JP; González-Billalabeitia E; Hung MC; Song SJ; Song MS
Cancer Cell; 2017 Feb; 31(2):208-224. PubMed ID: 28162974
[TBL] [Abstract][Full Text] [Related]
8. The ubiquitin-conjugating enzyme UBE2O modulates c-Maf stability and induces myeloma cell apoptosis.
Xu Y; Zhang Z; Li J; Tong J; Cao B; Taylor P; Tang X; Wu D; Moran MF; Zeng Y; Mao X
J Hematol Oncol; 2017 Jul; 10(1):132. PubMed ID: 28673317
[TBL] [Abstract][Full Text] [Related]
9. Autodeubiquitination protects the tumor suppressor BAP1 from cytoplasmic sequestration mediated by the atypical ubiquitin ligase UBE2O.
Mashtalir N; Daou S; Barbour H; Sen NN; Gagnon J; Hammond-Martel I; Dar HH; Therrien M; Affar el B
Mol Cell; 2014 May; 54(3):392-406. PubMed ID: 24703950
[TBL] [Abstract][Full Text] [Related]
10. Regulatory roles of an atypical ubiquitin ligase UBE2O in orphans of multiprotein complexes for degradation.
Lv Y; Xing F
Turk J Biol; 2022; 46(2):186-194. PubMed ID: 37533513
[TBL] [Abstract][Full Text] [Related]
11. UBE2O reduces the effectiveness of interferon-α via degradation of IFIT3 in hepatocellular carcinoma.
Li H; Liu Y; Cheng C; Wu Y; Liang SH; Wu L; Wang H; Tu CY; Yao HH; Meng FZ; Zhang B; Wang W; Wang JB; Liu LX
Cell Death Dis; 2023 Dec; 14(12):854. PubMed ID: 38129382
[TBL] [Abstract][Full Text] [Related]
12. Anatomic site-specific positive margins in organ-confined prostate cancer and its impact on outcome after radical prostatectomy.
Blute ML; Bostwick DG; Bergstralh EJ; Slezak JM; Martin SK; Amling CL; Zincke H
Urology; 1997 Nov; 50(5):733-9. PubMed ID: 9372884
[TBL] [Abstract][Full Text] [Related]
13. Tissue microarray sampling strategy for prostate cancer biomarker analysis.
Rubin MA; Dunn R; Strawderman M; Pienta KJ
Am J Surg Pathol; 2002 Mar; 26(3):312-9. PubMed ID: 11859202
[TBL] [Abstract][Full Text] [Related]
14. A muscle-specific UBE2O/AMPKα2 axis promotes insulin resistance and metabolic syndrome in obesity.
Vila IK; Park MK; Setijono SR; Yao Y; Kim H; Badin PM; Choi S; Narkar V; Choi SW; Chung J; Moro C; Song SJ; Song MS
JCI Insight; 2019 Jul; 4(13):. PubMed ID: 31292296
[TBL] [Abstract][Full Text] [Related]
15. Downregulated circular RNA itchy E3 ubiquitin protein ligase correlates with advanced pathologic T stage, high lymph node metastasis risk and poor survivals in prostate cancer patients.
Huang E; Chen X; Yuan Y
Cancer Biomark; 2019; 26(1):41-50. PubMed ID: 31306101
[TBL] [Abstract][Full Text] [Related]
16. Impact of positive surgical margins on prostate-specific antigen failure after radical prostatectomy in adjuvant treatment-naïve patients.
Ploussard G; Agamy MA; Alenda O; Allory Y; Mouracade P; Vordos D; Hoznek A; Abbou CC; de la Taille A; Salomon L
BJU Int; 2011 Jun; 107(11):1748-54. PubMed ID: 20883488
[TBL] [Abstract][Full Text] [Related]
17. Nuclear ELAC2 overexpression is associated with increased hazard for relapse after radical prostatectomy.
Schroeder C; Navid-Hill E; Meiners J; Hube-Magg C; Kluth M; Makrypidi-Fraune G; Simon R; Büscheck F; Luebke AM; Goebel C; Lang DS; Weidemann S; Neubauer E; Hinsch A; Jacobsen F; Lebok P; Michl U; Pehrke D; Huland H; Graefen M; Schlomm T; Sauter G; Höflmayer D
Oncotarget; 2019 Aug; 10(48):4973-4986. PubMed ID: 31452838
[TBL] [Abstract][Full Text] [Related]
18. Presence or absence of a positive pathological margin outperforms any other margin-associated variable in predicting clinically relevant biochemical recurrence in Gleason 7 prostate cancer.
Huang JG; Pedersen J; Hong MK; Harewood LM; Peters J; Costello AJ; Hovens CM; Corcoran NM
BJU Int; 2013 May; 111(6):921-7. PubMed ID: 23350712
[TBL] [Abstract][Full Text] [Related]
19. Stage T1-2 prostate cancer: a multivariate analysis of factors affecting biochemical and clinical failures after radical prostatectomy.
Kupelian PA; Katcher J; Levin HS; Klein EA
Int J Radiat Oncol Biol Phys; 1997 Mar; 37(5):1043-52. PubMed ID: 9169811
[TBL] [Abstract][Full Text] [Related]
20. Up-regulation of LIMK1 expression in prostate cancer is correlated with poor pathological features, lymph node metastases and biochemical recurrence.
Huang JB; Wu YP; Lin YZ; Cai H; Chen SH; Sun XL; Li XD; Wei Y; Zheng QS; Xu N; Xue XY
J Cell Mol Med; 2020 Apr; 24(8):4698-4706. PubMed ID: 32168432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
